Showing results (101-110 of 258) with videos related to

Sort By:
Pageof 26
Journal of Pineal Research|October 4, 2016
Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1Jianqiang Hu, Lei Zhang, Yang Yang, et al.
Medcomm|November 29, 2023
Low-dose exercise protects the heart against established myocardial infarction via IGF-1-upregulated CTRP9 in male miceYanzhen Tan, Pan Feng, Lele Feng, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 4, 2011
Regulation of in vivo cardiac contractility by phospholemman: role of Na+/Ca2+ exchangeJufang Wang, Erhe Gao, Joseph Rabinowitz, et al.
Free Radical Biology & Medicine|July 9, 2016
Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathwayHaifeng Pei, Jin Du, Xiaofeng Song, et al.
Oxidative Medicine and Cellular Longevity|March 27, 2018
ZP2495 Protects against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice through Improvement of Cardiac Metabolism and Mitochondrial Function: The Possible Involvement of AMPK-FoxO3a Signal PathwayShuang Li, Hao Wu, Dong Han, et al.
Circulation Research|April 3, 2010
Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivoKathleen C Woulfe, Erhe Gao, Hind Lal, et al.
Journal of Pineal Research|March 24, 2019
Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia/reperfusion injuryDong Han, Yongjun Wang, Jiangwei Chen, et al.
Circulation|September 20, 2019
MCUB Regulates the Molecular Composition of the Mitochondrial Calcium Uniporter Channel to Limit Mitochondrial Calcium Overload During StressJonathan P Lambert, Timothy S Luongo, Dhanendra Tomar, et al.
Plos One|May 25, 2013
Tumor necrosis factor-α and lymphotoxin-α mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2Yanqing Zhang, Jianli Zhao, Wayne Bond Lau, et al.
Cardiovascular Research|November 18, 2008
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonistsHui-Rong Liu, Ling Tao, Erhe Gao, et al.
Pageof 26